Clinical Trial

Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This trial is to assess the efficacy and feasibility of consolidation chemotherapy after neoadjuvant chemoradiotherapy for locally advanced mid or low rectal cancer.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2016-07-20; most recent amendment 2024-12-22.
Status change: Recruiting → Active, Not Recruiting 2024-12-22
Status change: Not Yet Recruiting → Recruiting 2017-01-06
Trial Details
NCT Number NCT02843191
Lead Sponsor Kyung Hee University Hospital at Gangdong
Collaborators: Korean Society of ColoProctology, Pharmbio Korea Inc., Samjin Pharmaceutical Co., Ltd., Boryung Pharmaceutical Co., Ltd, JW Pharmaceutical
Conditions Rectal Cancer
Enrollment 358 participants
Start Date 2016-12-07
Primary Completion 2023-07-15 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-27